3D model helps surgeons plan a complex spinal treatment

In complex surgical cases, planning ahead could mean the difference between success and failure. A recent study in Neuromodulation utilized 3D models as a way of allowing surgeons to practice on a patient with a previously untreated spinal condition.

The patient featured in the study could not receive neuromodulation—or an altering of nerve activity through targeted delivery of a stimulus to specific sites in the body—due to complications with his spinal anatomy. Without intrathecal access or an epidural, previous attempts at neuromodulation had failed. To navigate the patient’s unique spinal anatomy, clinicians used 3D printing to print a model of the his lower spine to improve the planning of the procedure and increase the odds of success.

With the opportunity to plan ahead and test different routes of access through the lower spine with the 3D model, clinicians successfully inserted a catheter into the patient and completed neuromodulation.

“Neuromodulation techniques can provide the optimal analgesic techniques for individual patients,” wrote first author Murray G. Taverner MBBS, of Monash University, and colleagues. “At times these can fail due to lack of access to the site for intervention, in this case epidural access. 3D printing may provide additional information to improve the likelihood of access when anatomy is distorted and standard approaches prove difficult.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup